Skip to main content

Integrated solutions for Tuberculosis control in animals combining vaccination and multi-species diagnostics

Objective

Recent studies have showed estimations of worldwide 50 million cattle infections with M. bovis, at a cost to the agricultural community of 2-3 billion € per year. In developing countries, M. bovis infection is still widespread, in both cattle and humans. Even in developed countries, successful eradication of disease from livestock is hampered by the presence of wildlife reservoirs of M. bovis. Under these circumstances, a single case of a reportable disease in livestock can result in serious economic consequences for the producer, public, and governments. Within this scenario, there’s room and clear business opportunities for integrated control products or solutions that aim at addressing what is considered a global problem, animal tuberculosis. Our overall objective is therefore to take the results of the TB-STEP project - “Strategies for the eradication of bovine tuberculosis”, funded under FP7-KBBE-2007 with project number 212414, where most of the WildTBVac partners were involved, and build a pre-commercial set of TB control solutions by means of testing the technical and economical viability of the aforementioned integrated approach. WildTBVac specific objectives are the following:
• To standardize and optimize the production of a TB Vaccine (prototype resulting of the TB-STEP project)
• To evaluate several vaccine-compatible diagnostic strategies (also resulting from the TB-STEP project) that will include multi-species DIVA tests (wild boar, domestic pigs, cattle)
• To assess the field efficacy of integrated TB control strategies including oral vaccination for TB control in wild boar
• To evaluate the field efficacy of integrated TB control strategies including oral vaccination for TB control in domestic and feral pigs
• To define the exploitation and commercialization strategy including clear technology transfer approaches and development of a market oriented business.

Call for proposal

FP7-KBBE-2013-7-single-stage
See other projects for this call

Coordinator

NEIKER-INSTITUTO VASCO DE INVESTIGACION Y DESARROLLO AGRARIO SA
Address
Berreaga Kalea 1
48160 Vizcaya
Spain
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 131 735
Administrative Contact
Yolanda Fernandez (Ms.)

Participants (7)

VACUNEK SL
Spain
EU contribution
€ 153 160
Address
Berreaga Kalea 1
48160 Derio
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Beatriz Lazaro (Ms.)
PRIONICS AG
Switzerland
EU contribution
€ 195 800
Address
Wagistrasse 27 A
8952 Schlieren
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Alex Raeber (Dr.)
Food and Environment Research Agency
United Kingdom
EU contribution
€ 73 681
Address
Area 1A, Nobel House, Smith Square 17
SW1P 3JR London
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Lucinda Cranham (Mrs.)
UNIVERSIDAD DE CASTILLA - LA MANCHA
Spain
EU contribution
€ 101 568
Address
Calle Altagracia 50
13071 Ciudad Real
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Maria Llanos Carrión Varela (Ms.)
ISTITUTO SUPERIORE DI SANITA
Italy
EU contribution
€ 94 160
Address
Viale Regina Elena 299
00161 Roma
Activity type
Research Organisations
Administrative Contact
Rosa Maria Martoccia (Dr.)
EUROFINS INGENASA SA
Spain
EU contribution
€ 160 100
Address
Avenida Institucion Libre De La Ensenaza 41
28037 Madrid
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Dominguez Eduardo (Mr.)
UNIVERSIDAD COMPLUTENSE DE MADRID
Spain
EU contribution
€ 88 000
Address
Avenida De Seneca 2
28040 Madrid
Activity type
Higher or Secondary Education Establishments
Administrative Contact
María Isabel Rodríguez Villa (Mrs.)